BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6140590)

  • 1. Can inhibition of hormone secretion be associated with endocrine tumour shrinkage?
    Kraenzlin ME; Ch'ng JC; Wood SM; Bloom SR
    Lancet; 1983 Dec 24-31; 2(8365-66):1501. PubMed ID: 6140590
    [No Abstract]   [Full Text] [Related]  

  • 2. Regression of metastatic vipoma with somatostatin analogue SMS 201-995.
    Clements D; Elias E
    Lancet; 1985 Apr; 1(8433):874-5. PubMed ID: 2858733
    [No Abstract]   [Full Text] [Related]  

  • 3. [Successful therapy of VIPoma with the long-acting somatostatin analogue SMS 201-995].
    Maeda M; Niitsu Y; Goto Y; Kogawa K; Watanabe N; Kohgo Y; Urushizaki I
    Nihon Naika Gakkai Zasshi; 1988 Jan; 77(1):86-90. PubMed ID: 2897419
    [No Abstract]   [Full Text] [Related]  

  • 4. Somatostatin analogue SMS 201-995 long term therapy for vipoma.
    Juby LD; Burke DA; Axon AT
    Postgrad Med J; 1987 Apr; 63(738):287-9. PubMed ID: 2891127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudopancreatic cholera syndrome: effect of a synthetic somatostatin analogue, SMS 201-995.
    Santangelo WC; Dueno MI; Krejs GJ
    Am J Med; 1987 May; 82(5B):84-7. PubMed ID: 2884881
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term treatment of a VIPoma with somatostatin analogue resulting in remission of symptoms and possible shrinkage of metastases.
    Kraenzlin ME; Ch'ng JL; Wood SM; Carr DH; Bloom SR
    Gastroenterology; 1985 Jan; 88(1 Pt 1):185-7. PubMed ID: 2856877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin and analogues in the treatment of VIPoma.
    O'Dorisio TM; Gaginella TS; Mekhjian HS; Rao B; O'Dorisio MS
    Ann N Y Acad Sci; 1988; 527():528-35. PubMed ID: 2898913
    [No Abstract]   [Full Text] [Related]  

  • 8. [Mixed endocrine tumor of the pancreas (vipoma, glucagonoma). Treatment by somatostatin followed by one of its long-acting analogs].
    Kaloustian E; Guillauseau PJ; Chayvialle JA; Veyssier P; Lallement PY; Latrive JP; Zylberait D; Lubetzki J
    Presse Med; 1987 Dec; 16(44):2217-20. PubMed ID: 2893369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin analogs in the management of gastrointestinal tumors.
    Lamberts SW
    Horm Res; 1988; 29(2-3):118-20. PubMed ID: 2900191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic cholera syndrome: effect of a synthetic somatostatin analog on intestinal water and ion transport.
    Santangelo WC; O'Dorisio TM; Kim JG; Severino G; Krejs GJ
    Ann Intern Med; 1985 Sep; 103(3):363-7. PubMed ID: 2862821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Octreotide--a synthetic somatostatin.
    Med Lett Drugs Ther; 1989 Jul; 31(796):66-8. PubMed ID: 2567960
    [No Abstract]   [Full Text] [Related]  

  • 12. Somatostatin analogue: use in the treatment of vipoma with hypercalcemia.
    Venkatesh S; Vassilopoulou-Sellin R; Samaan NA
    Am J Med; 1989 Sep; 87(3):356-7. PubMed ID: 2549791
    [No Abstract]   [Full Text] [Related]  

  • 13. Escape of the response to a long-acting somatostatin analogue (SMS 201-995) in patients with VIPoma.
    Koelz A; Kraenzlin M; Gyr K; Meier V; Bloom SR; Heitz P; Stalder H
    Gastroenterology; 1987 Feb; 92(2):527-31. PubMed ID: 2878857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Short-term treatment of a VIPoma with somatostatin analogue in advance of curative operation].
    Yoshioka M; Sakazume M; Fukagawa M; Seki T
    Nihon Naika Gakkai Zasshi; 1988 Aug; 77(8):1276-7. PubMed ID: 2853716
    [No Abstract]   [Full Text] [Related]  

  • 15. The somatostatin analogue SMS 201-995 in long-term treatment of vipoma. Case report.
    Christensen C
    Acta Chir Scand; 1989 Oct; 155(10):541-3. PubMed ID: 2557717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of somatostatin on diarrhea and on small intestinal water and electrolyte transport in a patient with pancreatic cholera.
    Ruskoné A; René E; Chayvialle JA; Bonin N; Pignal F; Kremer M; Bonfils S; Rambaud JC
    Dig Dis Sci; 1982 May; 27(5):459-66. PubMed ID: 6122550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vipoma, glucagonoma and the role of Sandostatin.
    Bloom SR
    NATNEWS; 1989 Jul; 26(7):15. PubMed ID: 2550822
    [No Abstract]   [Full Text] [Related]  

  • 18. Vasoactive intestinal peptide producing tumour contains high density of somatostatin receptors.
    Reubi JC; Heitz PU; Gyr K
    Lancet; 1987 Mar; 1(8535):741-2. PubMed ID: 2882148
    [No Abstract]   [Full Text] [Related]  

  • 19. An important new treatment for carcinoid tumors and VIPomas.
    Oncology (Williston Park); 1988 Dec; 2(12):35-6. PubMed ID: 2856315
    [No Abstract]   [Full Text] [Related]  

  • 20. Modulation of functional gastrointestinal endocrine tumors by endogenous and exogenous somatostatin.
    Ellison EC; O'Dorisio TM; Benson GD
    Am J Surg; 1986 Jun; 151(6):668-75. PubMed ID: 2872829
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.